7th International Conference on Tularemia 2012
7th International Conference on Tularemia 2012
批准号:
8319962
负责人:
John T Belisle
金额:
$0.5万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-05-15 至 2013-04-30
关键词:
Animal ModelAreaAwardBacteriaBooksCastorCategoriesCellular biologyCenters for Disease Control and Prevention (U.S.)ClassificationCollaborationsColoradoDevelopmentDiagnosisDiagnosticDiseaseEcologyEndemic DiseasesEpidemiologyEquipmentFeesFosteringFrancisellaFrancisella tularensisFundingGenomicsGoalsGrantHumanImmune responseImmunologyIndividualInfectionInstitutionInternationalLaboratoriesLeadLifeNational Institute of Allergy and Infectious DiseaseParticipantPathogenesisPopulation GeneticsPostdoctoral FellowPrincipal InvestigatorProteomicsPublic HealthResearchResearch PersonnelResortRunningScientistSecureStudentsTaxonomyTimeTravelTularemiaUnited States National Institutes of HealthVirulence FactorsVisualWorkbiodefensecostdata sharingfallsgraduate studentimprovedmeetingsnovel diagnosticspathogenposterssymposiumtherapeutic vaccine
中文摘要
描述(由申请人提供):兔热病是一种严重的致命性疾病,在整个北方半球流行。它是由土拉热弗朗西丝菌引起的,这是已知的最具传染性的病原体之一。F.土拉热菌已被归类为CDC和NIAID A类优先病原体,在生物防御方面具有最高的重要性。在过去的十年里,全世界积极参与F。tularensis研究。尽管有大量的研究积极集中在F。在土拉热病中,唯一一次将全世界科学家聚集在一起的会议是土拉热病国际会议,每三年举行一次。该项目的具体目标是获得资金,以帮助参加将于2012年秋季在科罗拉多举行的第七届土拉菌病国际会议的与会者。具体而言,需要资金支付所有与会者(估计275名与会者)的部分登记费,
为受训人员(估计有50名研究生)提供培训,并为6-8名本来无法参加会议的研究人员提供旅费。2012年第七届兔热病国际会议的总体目标是汇集来自学术、公共卫生、私营和国防机构的250-300名科学家以及临床医生、博士后研究员和研究生,介绍基因组学和蛋白质组学、发病机制、动物模型和毒力因子、人类感染和诊断、流行病学、生态学和种群遗传学/分类学,宿主反应,免疫学和细胞生物学,以及治疗学和疫苗。最终,科学家们有机会在这次会议上会面并讨论他们的个人研究成果,这将有助于激发新的想法,促进新的合作,并导致更快地开发改进的诊断,治疗和疫苗。土拉热。
公共卫生相关性:土拉菌病是一种危及生命的疾病,发生在整个北方;它具有生物防御和公共卫生意义,世界各地的许多实验室都在研究致病病原体土拉弗朗西斯菌。为了使与会者能够出席将于2012年9月17日至20日在科罗拉多举行的第七届土拉菌病国际会议,正在申请资金,以支付所有与会者(特别是学生)的注册费以及需要特别援助的与会者出席会议的差旅费。本次会议将为科学家提供机会,以满足和分享信息,促进新的合作,并最终有助于开发新的诊断,治疗和疫苗的兔热病。
英文摘要
DESCRIPTION (provided by applicant): Tularemia is a severe and fatal disease endemic throughout the Northern Hemisphere. It is caused by the bacterium Francisella tularensis, one of the most infectious pathogens known. F. tularensis has been classified as a CDC and NIAID Category A priority pathogen, of highest importance with respect to biodefense. In the last decade there has been a large increase in the number scientists worldwide actively engaged in F. tularensis research. Despite the amount of research actively focused on F. tularensis, the only meeting to bring together scientists worldwide is the International Conference on Tularemia, which only occurs every three years. The specific aim of this project is to secure funding to aid participant attendance at the 7th International Conference on Tularemia to be held in Colorado in the Fall of 2012. Specifically, funds are requested to defray a portion of registration costs for all participants (estimated 275 attendees), further defray registration fees
for trainees (estimated 50 graduate students) and provide travel for 6-8 researchers who would not otherwise be able to attend the conference. The overall objective of the 7th International Conference on Tularemia 2012 is to bring together 250-300 scientists from academic, public health, private and defense institutions as well as clinicians, postdoctoral fellows and graduate students to present the latest findings in the key theme areas of genomics and proteomics, pathogenesis, animal model and virulence factors, human infection and diagnosis, epidemiology, ecology and populations genetics/taxonomy, host response, immunology and cell biology, and therapeutics and vaccines. Ultimately, the opportunity for scientists to meet and discuss their individual research findings at this conference should serve to spark new ideas, foster new collaborations, and lead to more rapid development of improved diagnostics, therapeutics and vaccines for F. tularensis.
PUBLIC HEALTH RELEVANCE: Tularemia is a life-threatening disease which occurs throughout the Northern Hemisphere; it is of biodefense and public health significance with many laboratories worldwide studying the causative pathogen, Francisella tularensis. To enable attendance at the 7th International Conference on Tularemia to be held in Colorado September 17-20, 2012, funds are being requested to defray costs of registration fees for all participants (particularly students) as well as travel costs for attendees requiring special assistance to atten the meeting. This conference will provide the opportunity for scientists to meet and share information, foster new collaborations, and ultimately contribute to the development of new diagnostics, therapeutics and vaccines for tularemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)
-
批准号:10197000
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2020
-
负责人:John T Belisle
-
依托单位:
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)
-
批准号:10418673
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2020
-
负责人:John T Belisle
-
依托单位:
Evaluation of new diagnostics for incident, active and recurrent TB (ENDx-Tb)
-
批准号:9981167
-
项目类别:
-
资助金额:$150.0万
-
财政年份:2020
-
负责人:John T Belisle
-
依托单位:
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease
-
批准号:10409724
-
项目类别:
-
资助金额:$75.23万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy
-
批准号:10674122
-
项目类别:
-
资助金额:$17.79万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy
-
批准号:10430146
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy
-
批准号:9978702
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease
-
批准号:10199751
-
项目类别:
-
资助金额:$75.34万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease
-
批准号:10674095
-
项目类别:
-
资助金额:$43.87万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy
-
批准号:10651645
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
Host Metabolic Biosignatures for the Diagnosis of Lyme Disease
-
批准号:10626133
-
项目类别:
-
资助金额:$75.14万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy
-
批准号:10203791
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2019
-
负责人:John T Belisle
-
依托单位:
Biology and Biosignatures of Anti-Tuberculosis Treatment Response
-
批准号:9220717
-
项目类别:
-
资助金额:$58.53万
-
财政年份:2015
-
负责人:John T Belisle
-
依托单位:
Biology and Biosignatures of Anti-Tuberculosis Treatment Response
-
批准号:8997444
-
项目类别:
-
资助金额:$61.99万
-
财政年份:2015
-
负责人:John T Belisle
-
依托单位:
Metabolic biomarkers and biosignatures for improved diagnosis of Lyme disease
-
批准号:8841454
-
项目类别:
-
资助金额:$45.55万
-
财政年份:2014
-
负责人:John T Belisle
-
依托单位:
Metabolic biomarkers and biosignatures for improved diagnosis of Lyme disease
-
批准号:8301968
-
项目类别:
-
资助金额:$21.62万
-
财政年份:2012
-
负责人:John T Belisle
-
依托单位:
Metabolic biomarkers and biosignatures for improved diagnosis of Lyme disease
-
批准号:8471053
-
项目类别:
-
资助金额:$20.42万
-
财政年份:2012
-
负责人:John T Belisle
-
依托单位:
Regulation of lipid biosynthesis in Mycobacterium tuberculosis
-
批准号:8094156
-
项目类别:
-
资助金额:$18.51万
-
财政年份:2011
-
负责人:John T Belisle
-
依托单位:
Administrative Core
-
批准号:8261436
-
项目类别:
-
资助金额:$50.46万
-
财政年份:2011
-
负责人:John T Belisle
-
依托单位:
Regulation of lipid biosynthesis in Mycobacterium tuberculosis
-
批准号:8339438
-
项目类别:
-
资助金额:$18.57万
-
财政年份:2011
-
负责人:John T Belisle
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: